Juno Therapeutics (JUNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -437,106 | -245,580 | -239,376 | -243,407 | -51,820 |
| Depreciation Amortization | 23,632 | 14,186 | 6,041 | 395 | 2 |
| Income taxes - deferred | -6,016 | -10,617 | -2,760 | 0 | N/A |
| Accounts receivable | -623 | -12,968 | 33 | 0 | N/A |
| Accounts payable and accrued liabilities | 46,900 | 2,238 | 21,783 | 1,619 | 1,098 |
| Other Working Capital | 113,971 | -25,052 | 211,628 | 79,159 | 10,806 |
| Other Operating Activity | 34,209 | 87,984 | 9,976 | 79,689 | 9,404 |
| Operating Cash Flow | $-225,033 | $-189,809 | $7,325 | $-82,545 | $-30,510 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -710,745 | -750,344 | -1,315,597 | -121,827 | N/A |
| PPE Investments | -60,924 | -56,246 | -28,184 | -2,958 | -42 |
| Net Acquisitions | N/A | -74,575 | -77,666 | N/A | N/A |
| Sale Of Investment | 703,459 | 969,720 | 459,381 | 0 | N/A |
| Investing Cash Flow | $-68,210 | $88,555 | $-962,066 | $-124,785 | $-42 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 10,804 | N/A | N/A | N/A | N/A |
| Debt Repayment | -161 | -369 | -249 | N/A | N/A |
| Common Stock Issued | 327,522 | 51,786 | 851,487 | 281,383 | 12 |
| Common Stock Repurchased | 0 | -10,073 | 0 | 0 | N/A |
| Other Financing Activity | 0 | -4,562 | 0 | 245,949 | 66,506 |
| Financing Cash Flow | $338,165 | $36,782 | $851,238 | $527,332 | $66,518 |
| Exchange Rate Effect | -32 | -35 | -67 | N/A | N/A |
| Beginning Cash Position | 187,891 | 252,398 | 355,968 | 35,966 | N/A |
| End Cash Position | 232,781 | 187,891 | 252,398 | 355,968 | 35,966 |
| Net Cash Flow | $44,890 | $-64,507 | $-103,570 | $320,002 | $35,966 |
| Free Cash Flow | |||||
| Operating Cash Flow | -225,033 | -189,809 | 7,325 | -82,545 | -30,510 |
| Capital Expenditure | -60,924 | -56,246 | -28,184 | -2,958 | -42 |
| Free Cash Flow | -285,957 | -246,055 | -20,859 | -85,503 | -30,552 |